<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T22:21:44Z</responseDate><request verb="GetRecord" identifier="oai:digital.lib.washington.edu:1773/44875" metadataPrefix="dim">https://digital.lib.washington.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:digital.lib.washington.edu:1773/44875</identifier><datestamp>2026-02-15T21:27:06Z</datestamp><setSpec>com_1773_4888</setSpec><setSpec>col_1773_4952</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Sarkar, Surojit</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" authority="d248a3ee-5689-44c2-84a8-8aff70e6f569" confidence="300">Yuzefpolskiy, Yevgeniy</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2019-10-15T23:00:51Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2019-10-15</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2019</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">Yuzefpolskiy_washington_0250E_20742.pdf</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/1773/44875</dim:field>
   <dim:field mdschema="dc" element="description">Thesis (Ph.D.)--University of Washington, 2019</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">IL-2 is a potent cytokine in mediating antigen-specific CD8 T cell responses. Following antigen priming, IL-2 signals drive the differentiation of resting cytotoxic T cells into potent effector cells to elicit rapid expansion, and the expression of effector molecules critical for eradicating intracellular infections. Antigen-specific CD8 T cells more sensitive to early IL-2 signals undergo pronounced effector expansion as they differentiate into terminal effector cells that subsequently undergo substantial contraction following antigen clearance. Conversely, cells expressing lower levels of the high affinity IL-2 receptor, CD25, exhibit lesser expansion and preferentially form long-lived memory CD8 T cells, which provide protection from future infections. Interestingly, one of the hallmark features of these memory CD8 T cells is their retained function of autocrine IL-2 production. This suggests that autocrine IL-2 is intrinsically linked to the differentiation and maintenance of effector and memory cells. In our studies we have utilized a murine model of acute infection in which we studied the effects of autocrine IL-2 ablation on antigen-specific CD8 T cells. We were able to show that autocrine IL-2 signals were dispensable to antigen-specific CD8 T cells for mounting a primary immune response; the T cells showed no defect in effector expansion or function, and were capable of forming long-lived, polyfunctional memory CD8 T cells. However, upon antigenic rechallenge memory cells deficient in autocrine IL-2 signals underwent increased cell-death resulting in a compromised secondary response. We then used temporal ablation of autocrine IL-2 to determine that these signals were critical during the initial priming of antigen-specific CD8 T cells. Unlike acute infections, where antigen is cleared by the effector response, during chronic infections antigen persists in the host exhausting the antigen-specific T cells via constant stimulation. However, the initial priming events are similar in both acute and chronic IL-2 infections. Thus, we wanted to determine if autocrine IL-2 signals also program survival in CD8 T cells in a system where the cells are continuously stimulated with antigen. We discovered that in the absence of autocrine IL-2, antigen-specific CD8 T cells undergo lower expansion but are not affected in their ability to elicit effector function. Following establishment of exhaustion, CD8 T cells lacking autocrine IL-2 over-expressed inhibitory receptor PD-1, and had a pronounced defect in maintenance. Surprisingly, T cells lacking autocrine IL-2 underwent significantly better expansion following PDL1 checkpoint blockade therapy, expanding to levels similar to their WT counterparts. These data show for the first time a critical role for autocrine IL-2 during chronic infections. Furthermore, this research suggests that it is possible to tune exhausted CD8 T cells using IL-2 signals, to boost their responsiveness to checkpoint blockade therapy.</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en_US</dim:field>
   <dim:field mdschema="dc" element="rights">none</dim:field>
   <dim:field mdschema="dc" element="subject">Autocrine IL-2</dim:field>
   <dim:field mdschema="dc" element="subject">CD8 T cell</dim:field>
   <dim:field mdschema="dc" element="subject">Chronic</dim:field>
   <dim:field mdschema="dc" element="subject">CRISPR</dim:field>
   <dim:field mdschema="dc" element="subject">cytotoxic T cell</dim:field>
   <dim:field mdschema="dc" element="subject">LCMV</dim:field>
   <dim:field mdschema="dc" element="subject">Immunology</dim:field>
   <dim:field mdschema="dc" element="subject" qualifier="other">Pathology</dim:field>
   <dim:field mdschema="dc" element="title">The Role of Early Autocrine IL-2 Signals in Programming Antigen-Specific CD8 T cell Responses</dim:field>
   <dim:field mdschema="dc" element="type">Thesis</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="terms">Delay release for 1 year -- then make Open Access</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="lift">2020-10-14T23:00:51Z</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>